StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$227.97−4.26 (-1.83%)

Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –

Danaher Biotechnology — Reported GAAP Operating Margin by Quarter

Biotechnology — Reported GAAP Operating Margin (%)

QuarterlyAnnual

Danaher Biotechnology — Reported GAAP Operating Margin: 26.4% in Q3 2026, up 6.8 pts from a year earlier.

Latest, Q3 2026
26.4%
Period ended Sep 30, 2026
Change on a year earlier
+6.8 pts
19.6% in Q3 2025
History
19 quarters
Since Q1 2022
Sources
11
Documents cited below

Where the Q3 2026 figure comes from

Source: Danaher IR — nongaap_2026Q3 ↗

Reported in Danaher Non-GAAP Reconciliations & Supplemental Data (8-K / IR PDF).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBiotechnology — Reported GAAP Operating Margin (%)Year on yearSource
Q3 2026Sep 30, 202626.4%+6.8 ptsDanaher IR — nongaap_2026Q3 ↗
Q2 2026Jun 30, 202629.0%+0.3 ptsDanaher IR — nongaap_2026Q2 ↗
Q1 2026Mar 31, 202629.7%+2.3 ptsDanaher IR — nongaap_2026Q1 ↗
Q4 2025Dec 31, 202526.6%-0.6 ptsDanaher IR — nongaap_2025Q4 ↗
Q3 2025Sep 30, 202519.6%-4.0 ptsDanaher IR — nongaap_2026Q3 ↗
Q2 2025Jun 30, 202528.7%+1.7 ptsDanaher IR — nongaap_2026Q2 ↗
Q1 2025Mar 31, 202527.4%+6.1 ptsDanaher IR — nongaap_2026Q1 ↗
Q4 2024Dec 31, 202427.2%+3.6 ptsDanaher IR — nongaap_2025Q4 ↗
Q3 2024Sep 30, 202423.6%-1.5 ptsDanaher IR — nongaap_2025Q3 ↗
Q2 2024Jun 30, 202427.0%+1.5 ptsDanaher IR — nongaap_2025Q2 ↗
Q1 2024Mar 31, 202421.3%-10.7 ptsDanaher IR — nongaap_2025Q1 ↗
Q4 2023Dec 31, 202323.6%-7.6 ptsDanaher IR — nongaap_2024Q4 ↗
Q3 2023Sep 30, 202325.1%-8.6 ptsDanaher IR — nongaap_2024Q3 ↗
Q2 2023Jun 30, 202325.5%-10.9 ptsDanaher IR — nongaap_2024Q2 ↗
Q1 2023Mar 31, 202332.0%-4.1 ptsDanaher IR — nongaap_ex_veralto ↗
Q4 2022Dec 31, 202231.2%–Danaher IR — nongaap_ex_veralto ↗

Cite this data

StockData. (2026). Danaher Biotechnology — Reported GAAP Operating Margin (%), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/gaap-op-margin-biotech

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.